Physician profile
Kyle Thomas Johnson
NPI 1538659420
$6,997.69
in general payments reported to CMS, 2019-2025
18 companies · $6,435 in 2025
The $6,435 reported for 2025 was more than what 92% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $563 · 2025: $6,435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $3,125 · Food and Beverage: $2,079 · Travel and Lodging: $1,344 · Education: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $3,125.00 |
| Food and Beverage | $2,078.82 |
| Travel and Lodging | $1,343.87 |
| Education | $450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $5,599.44 | 2024-2025 | |
| Janssen Biotech, INC. | $237.44 | 2024-2025 | Rybrevant, Carvykti, Erleada |
| Bioprotect Medical, INC. | $184.68 | 2024 | Bioprotect Balloon Implant System |
| Intuitive Surgical, INC. | $182.28 | 2025 | |
| Janssen Scientific Affairs, LLC | $127.53 | 2025 | |
| Calyxo, INC. | $125.52 | 2025 | Cvac Aspiration System |
| Exelixis INC. | $122.28 | 2024 | Cabometyx |
| Boston Scientific Corporation | $118.48 | 2024-2025 | Lithovue, General - Erectile Dysfunction, Axonics |
| Ethicon US, LLC | $47.62 | 2025 | Echelon Flex, Ethicon |
| Ferring Pharmaceuticals INC. | $47.38 | 2025 | Adstiladrin |
| C. R. Bard, INC. & Subsidiaries | $36.41 | 2025 | Magic3 Go Intermittent Urinary Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $31.83 | 2024 | |
| Merck Sharp & Dohme LLC | $31.67 | 2025 | Keytruda |
| Procept Biorobotics Corporation | $29.40 | 2025 | |
| Myriad Genetic Laboratories, INC. | $23.44 | 2025 | Prolaris |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $19.43 | 2025 | Posluma |
| Abbvie INC. | $17.82 | 2025 | |
| Astellas Pharma US INC | $15.04 | 2024 | Xtandi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.